CRYO-CELL INTERNATIONAL, INC. Net Cash Provided by (Used in) Investing Activities, Continuing Operations
CRYO-CELL INTERNATIONAL, INC. (CCEL) reported Net Cash Provided by (Used in) Investing Activities, Continuing Operations of -$481.87 thousand for the 3-month period ending 2018-02-28, per its 10-Q filed 2018-04-16.
Discontinued › Cash Flow › Investing Activities
us-gaap:NetCashProvidedByUsedInInvestingActivitiesContinuingOperations · last filed 2018-04-16
- CRYO-CELL INTERNATIONAL, INC. net cash provided by (used in) investing activities, continuing operations for the quarter ending 2018-02-28 was -$481.87K, a 460.88% decline year-over-year.
- CRYO-CELL INTERNATIONAL, INC. net cash provided by (used in) investing activities, continuing operations for the quarter ending 2017-11-30 was -$12.82K.
- CRYO-CELL INTERNATIONAL, INC. net cash provided by (used in) investing activities, continuing operations for the quarter ending 2017-08-31 was -$62.18K, a 521.22% decline year-over-year.
- CRYO-CELL INTERNATIONAL, INC. net cash provided by (used in) investing activities, continuing operations for the quarter ending 2017-05-31 was $34.49K.
- CRYO-CELL INTERNATIONAL, INC. net cash provided by (used in) investing activities, continuing operations for fiscal 2017 was $93.03K.
- CRYO-CELL INTERNATIONAL, INC. net cash provided by (used in) investing activities, continuing operations for fiscal 2016 was -$369.73K.
- CRYO-CELL INTERNATIONAL, INC. net cash provided by (used in) investing activities, continuing operations for fiscal 2015 was -$719.35K, a 283.88% decline from fiscal 2014.
- CRYO-CELL INTERNATIONAL, INC. net cash provided by (used in) investing activities, continuing operations for fiscal 2014 was $391.21K, a 65.97% decline from fiscal 2013.
| Period end | Net Cash Provided by (Used in) Investing Activities, Continuing Operations 3 month | Net Cash Provided by (Used in) Investing Activities, Continuing Operations 6 month | Net Cash Provided by (Used in) Investing Activities, Continuing Operations 9 month | Net Cash Provided by (Used in) Investing Activities, Continuing Operations 12 month |
|---|---|---|---|---|
| 2018-02-28 | -$481.87K 10-Q · filed 2018-04-16 | -$494.68K derived: sum of 2 quarters · filed 2018-04-16 | -$556.86K derived: sum of 3 quarters · filed 2018-04-16 | -$522.37K derived: sum of 4 quarters · filed 2018-04-16 |
| 2017-11-30 | -$12.82K derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-28 | -$74.99K derived: sum of 2 quarters · filed 2018-02-28 | -$40.50K derived: sum of 3 quarters · filed 2018-02-28 | $93.03K 10-K · filed 2018-02-28 |
| 2017-08-31 | -$62.18K derived: 10-Q 9 month − 10-Q 6 month · filed 2017-10-16 | -$27.68K derived: sum of 2 quarters · filed 2017-10-16 | $105.84K 10-Q · filed 2017-10-16 | $33.30K derived: sum of 4 quarters · filed 2018-04-16 |
| 2017-05-31 | $34.49K derived: 10-Q 6 month − 10-Q 3 month · filed 2017-07-07 | $168.02K 10-Q · filed 2017-07-07 | $95.47K derived: sum of 3 quarters · filed 2018-04-16 | $110.23K derived: sum of 4 quarters · filed 2018-04-16 |
| 2017-02-28 | $133.53K 10-Q · filed 2018-04-16 | $60.98K derived: sum of 2 quarters · filed 2018-04-16 | $75.74K derived: sum of 3 quarters · filed 2018-04-16 | -$48.19K derived: sum of 4 quarters · filed 2018-04-16 |
| 2016-11-30 | -$72.54K derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-28 | -$57.78K derived: sum of 2 quarters · filed 2018-02-28 | -$181.71K derived: sum of 3 quarters · filed 2018-02-28 | -$369.73K 10-K · filed 2018-02-28 |
| 2016-08-31 | $14.76K derived: 10-Q 9 month − 10-Q 6 month · filed 2017-10-16 | -$109.17K derived: sum of 2 quarters · filed 2017-10-16 | -$297.18K 10-Q · filed 2017-10-16 | -$534.97K derived: sum of 4 quarters · filed 2017-10-16 |
| 2016-05-31 | -$123.93K derived: 10-Q 6 month − 10-Q 3 month · filed 2016-07-11 | -$311.94K 10-Q · filed 2017-07-07 | -$549.73K derived: sum of 3 quarters · filed 2017-04-13 | -$786.82K derived: sum of 4 quarters · filed 2017-04-13 |
| 2016-02-29 | -$188.02K 10-Q · filed 2017-04-13 | -$425.80K derived: sum of 2 quarters · filed 2017-04-13 | -$662.89K derived: sum of 3 quarters · filed 2017-04-13 | -$888.42K derived: sum of 4 quarters · filed 2017-04-13 |
| 2015-11-30 | -$237.79K derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-28 | -$474.88K derived: sum of 2 quarters · filed 2017-02-28 | -$700.40K derived: sum of 3 quarters · filed 2017-02-28 | -$719.35K 10-K · filed 2017-02-28 |
| 2015-08-31 | -$237.09K derived: 10-Q 9 month − 10-Q 6 month · filed 2016-10-17 | -$462.62K derived: sum of 2 quarters · filed 2016-10-17 | -$481.56K 10-Q · filed 2016-10-17 | -$526.17K derived: sum of 4 quarters · filed 2016-10-17 |
| 2015-05-31 | -$225.53K derived: 10-Q 6 month − 10-Q 3 month · filed 2016-07-11 | -$244.47K 10-Q · filed 2016-07-11 | -$289.08K derived: sum of 3 quarters · filed 2016-07-11 | -$328.68K derived: sum of 4 quarters · filed 2016-07-11 |
| 2015-02-28 | -$18.95K 10-Q · filed 2016-04-14 | -$63.55K derived: sum of 2 quarters · filed 2016-04-14 | -$103.15K derived: sum of 3 quarters · filed 2016-04-14 | $495.81K derived: sum of 4 quarters · filed 2016-04-14 |
| 2014-11-30 | -$44.61K derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-29 | -$84.21K derived: sum of 2 quarters · filed 2016-02-29 | $514.75K derived: sum of 3 quarters · filed 2016-02-29 | $391.21K 10-K · filed 2016-02-29 |
| 2014-08-31 | -$39.60K derived: 10-Q 9 month − 10-Q 6 month · filed 2015-10-15 | $559.36K derived: sum of 2 quarters · filed 2015-10-15 | $435.81K 10-Q · filed 2015-10-15 | $721.63K derived: sum of 4 quarters · filed 2015-10-15 |
| 2014-05-31 | $598.96K derived: 10-Q 6 month − 10-Q 3 month · filed 2015-07-15 | $475.42K 10-Q · filed 2015-07-15 | $761.23K derived: sum of 3 quarters · filed 2015-07-15 | $1.83M derived: sum of 4 quarters · filed 2015-07-15 |
| 2014-02-28 | -$123.54K 10-Q · filed 2015-04-14 | $162.27K derived: sum of 2 quarters · filed 2015-03-02 | $1.23M derived: sum of 3 quarters · filed 2015-03-02 | $1.10M derived: sum of 4 quarters · filed 2015-03-02 |
| 2013-11-30 | $285.82K derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-02 | $1.36M derived: sum of 2 quarters · filed 2015-03-02 | $1.23M derived: sum of 3 quarters · filed 2015-03-02 | $1.15M 10-K · filed 2015-03-02 |
| 2013-08-31 | $1.07M derived: 10-Q 9 month − 10-Q 6 month · filed 2014-10-15 | $940.60K derived: sum of 2 quarters · filed 2014-10-15 | $863.64K 10-Q · filed 2014-10-15 | |
| 2013-05-31 | -$129.22K derived: 10-Q 6 month − 10-Q 3 month · filed 2014-07-03 | -$206.17K 10-Q · filed 2014-07-03 | ||
| 2013-02-28 | -$76.96K 10-Q · filed 2014-04-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| MANGOCEUTICALS, INC. (MGRX) | United States | $0.010B | -0.43 |
| BioRestorative Therapies, Inc. (BRTX) | United States | $0.064B | |
| Park Dental Partners, Inc. (PARK) | United States | $0.094B | |
| VIEMED HEALTHCARE, INC. (VMD) | United States | $0.336B | 29.92 |
| agilon health, inc. (AGL) | United States | $1.272B | -7.76 |
| Progyny, Inc. (PGNY) | United States | $1.994B | 28.37 |
| Sotera Health Co (SHC) | United States | $5.271B | 30.96 |
| DAVITA INC. (DVA) | United States | $11.147B | 16.80 |